S. Thaler

A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.

B. Schnierle, S. Thaler, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

MLV/HIV-pseudotyped vectors: a new treatment option for cutaneous T cell lymphomas.

B. Schnierle, A. Burger, T. Schulz, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.

B. Groner, B. Schnierle, S. Thaler, 1999, Virology.

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors

S. Siegert, R. Wagner, B. Schnierle, 2005, AIDS research and therapy.

Establishment of a mouse xenograft model for mycosis fungoides

R. Dummer, B. Schnierle, A. Burger, 2004, Experimental dermatology.

Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry

B. Fehse, B. Schnierle, G. Stiegler, 2001, Journal of Virology.